🇺🇸 FDA
Patent

US 11786540

Gliflozins and a method for their delivery during resuscitation from cardiac arrest to improve survival outcomes

granted A61KA61K31/7048

Quick answer

US patent 11786540 (Gliflozins and a method for their delivery during resuscitation from cardiac arrest to improve survival outcomes) held by THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/7048